by Scott Larrivee | Nov 6, 2025 | Blog
Nov. 6, 2025 – Nusano CEO, Chris Lowe, is the featured guest on the new edition of the Healthcare Technology Report podcast with RJ Lumba. The two discuss: Nusano’s breakthrough radioisotope production platform; The company’s endeavors beyond life...
by Scott Larrivee | Jun 26, 2025 | Blog
Nusano’s CEO, Chris Lowe, recently spoke to Ravi Kumar for the Connor Group’s Breakthrough Work podcast. The discussion covered: How Chris went from being CFO to leading Nusano as their CEO How Nusano technology is changing pharma, energy, and other...
by Scott Larrivee | May 29, 2025 | Podcast
In this episode of Talk Radioisotopes, host Scott Larrivee sits down with Sigal Kalmanson, CEO and Co-Founder of Starget Pharma, an early-stage company at the forefront of precision oncology. Starget is redefining the way radiopharmaceuticals are discovered and...
by Scott Larrivee | May 16, 2025 | Podcast
In this episode, Milton Lönnroth, Co-Founder and CEO, shares how Atley Solutions is changing the game for astatine-211, a promising isotope in cancer therapy. Atley supports radiopharmaceutical companies and researchers by enabling the scalable production and labeling...
by Scott Larrivee | Apr 30, 2025 | Podcast
In this episode, host Scott Larrivee speaks with Dr. Luke Nordquist, a medical oncologist and Founder/CEO of XCancer, a globally recognized clinical research center. Dr. Nordquist shares the origin story of XCancer—born out of a desire to bring cutting-edge prostate...
